Surgical adjuvant hormonal therapy with high dose medroxyprogesterone acetate (MAP) in breast cancer. Results 36 months after mastectomy.
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008408:Mastectomy; D008525:Medroxyprogesterone / Q000008:administration & dosage*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D011182:Postoperative Care
D008525:Medroxyprogesterone